Stable coronary heart disease (syndrome of cardiac blood stasis)
Conditions
Interventions
Therapeutic group:Take orally 4 capsules three times a day after meals. 30 days is a course of treatment
Sponsors
Zhejiang Hospital
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Aged 18 to 75 years old, regardless of gender; 2. Consistent with Western diagnostic criteria for angina pectoris of stable coronary heart disease (refer to 2018 Guidelines for Diagnosis and Treatment of Stable Coronary Heart Disease); 3. The patient has the main symptoms of chest pain and chest tightness, which meets the TCM diagnosis criteria of coronary heart disease, angina pectoris, blood blood stasis syndrome (Appendix 18.3); 4. Sign informed consent voluntarily.
Exclusion criteria
Exclusion criteria: 1. Patients with poor blood pressure control (systolic blood pressure >= 180 mmHg and/or diastolic blood pressure >= 110 mmHg); 2. Patients with severe cardiac insufficiency (cardiac function grade IV), severe arrhythmia and other serious heart diseases; 3. Pregnant and lactating women; 4. Patients with gastric and duodenal ulcers and other gastrointestinal bleeding tendency in the active stage; 5. APTT Upper limit of 1.5 times normal; 6. Abnormal liver and kidney function (ALT, AST, TBIL or SCr greater than 1.5 times the upper limit of normal); 7. Patients who are considered unsuitable for this clinical trial by investigators.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| physical examination;Vital signs;blood biochemistry;Blood RT;Urinalysis;stool for routine;coagulation function;12-lead electrocardiogram;adverse event; | — |
Secondary
| Measure | Time frame |
|---|---|
| The incidence rate of TCM syndrome efficacy is judged to be obvious and effective;the incidence of angina symptoms were significant or improved;Incidence of discontinuation and halving of medication use for acute angina attacks; | — |
Countries
China
Contacts
Public ContactJing Yan
Zhejiang Hospital
Outcome results
None listed